(Q42440688)

English

Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome

scientific article published on April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

Tropeano G

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Liberale I

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Vuolo IP

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Barini A

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Caroli G

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Carfagna P

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Menini E

7

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Journal of Endocrinological Investigation

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

220-224

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

https://scigraph.springernature.com/pub.10.1007/bf03346907

0 references

Dysfunction of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Effects of insulin on rat anterior pituitary cells. Inhibition of growth hormone secretion and mRNA levels

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Somatomedin-C Mediates Growth Hormone Negative Feedback by Effects on Both the Hypothalamus and the Pituitary

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Insulin-like growth factor-I action on growth hormone secretion and messenger ribonucleic acid levels: interaction with somatostatin

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Polycystic ovarian disease: Endocrinological parameters with specific reference to growth hormone and somatomedin-C

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man and its impairment in acromegalic patients

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Interactions between insulin and insulin-like growth factor I in the pathogenesis of polycystic ovarian disease.

1 reference

https://api.crossref.org/works/10.1007%2FBF03346907

21 January 2018

Growth hormone response to L-dopa and pyridostigmine in women with polycystic ovarian syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrine aspects of obesity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polycystic ovaries in non-obese and obese patients: possible pathophysiological mechanism based on new interpretation of facts and findings

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished growth hormone responses to L-dopa in polycystic ovarian disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An abnormality of the growth hormone/insulin-like growth factor-I axis in women with polycystic ovary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9211130

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF03346907

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42440688&oldid=1957073751"